<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Blood Cancer

Patient Care    Blood Cancer    Leukemia

Acute Myeloid Leukemia (AML) Won’t Slow World Champion Triathlete Down

Siri Lindley couldn’t swim. She had never learned how. So the idea of competing in a triathlon seemed completely out of the question.

“I couldn’t help but fall in love with the sport,” says Siri. “Something about it drew me in and I knew I had to start training.”


Author Cancer Center | Publish Date September 02, 2020
Full Story

Research    Blood Cancer

CU Cancer Center Effort to Link Underrepresented Patients with Leukemia with Cutting Edge Treatments

A key component in treating newly diagnosed leukemia is genetic and molecular testing. With this knowledge, physicians can better determine which treatment options are best suited for patients based on genetic mutations, fusions and other biologic features. 


Author Cancer Center | Publish Date August 05, 2020
Full Story

CU Cancer Center In the News

OncLive

Dr. Schenk on the Evolving Treatment Landscape in Lung Cancer

news outletOncLive
Publish DateAugust 25, 2020

Erin Schenk, MD, PhD, University of Colorado Cancer Center member, discusses the rapidly evolving treatment landscape in lung cancer.

Full Story
OncLive

Dr. Bunn on Targeting HER3 in NSCLC

news outletOncLive
Publish DateAugust 18, 2020

Paul A. Bunn, Jr, MD, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado, and a 2014 Giant of Cancer Care® in Lung Cancer, discusses potentially targeting HER3 in non–small cell lung cancer (NSCLC).

Full Story
Oncology Learning Network

Oral Apixaban Preferable for Preventing Postsurgery VTE in Patients With Gynecologic Cancer

news outletOncology Learning Network
Publish DateAugust 10, 2020

“Current guidelines recommend a 28-day course of enoxaparin for thromboprophylaxis after surgery for gynecologic cancer,” wrote Saketh R. Guntupalli, Director of the Division of Gynecologic Oncology, University of Colorado School of Medicine, and colleagues.

Full Story
OncLive

Dr. Bunn on Data With Trastuzumab Deruxtecan in HER2-Mutant NSCLC

news outletOncLive
Publish DateJuly 27, 2020

Paul A. Bunn, Jr, distinguished professor, James Dudley Chair in Lung Cancer Research, Division of Medical Oncology, University of Colorado and a 2014 Giant of Cancer Care® in Lung Cancer, highlights encouraging data with fam-trastuzumab deruxtecan-nxki (Enhertu) in HER2-mutant non–small cell lung cancer (NSCLC).

Full Story